- Amazon is providing prices and wait times for primary care.
- The CDC officials “used inaccurate information and misrepresented medical research” to promote mask wearing.
- CDC report: 1 in 5 women receiving maternity care were mistreated and almost 1 in 3 experienced discrimination because of age, weight, income, etc.
- Tyler Cowen and Alex Tabarrok reflect on their 20-year-old blog.
- Nearly 160 Wall Street firms have moved their headquarters out of New York, taking nearly $1 trillion in assets under management with them. (Bloomberg)
Category: Policy & Legislation
Universal Coverage Will Not Cure Health Inequity
The United States spends about twice as much per capita on health care as other high-income countries. Yet our health outcomes are not as good, on average. It’s not that all Americans are in poor health, it’s that some Americans are in poor health and pulling down the average. As I’ve said before, health is correlated with wealth and education. Wealthier is healthier.
How Medicare Encourages Hospitals to Monopolize the Medical Marketplace
In 2016, the first hour of chemotherapy infusion — one of the most common services billed by oncology practices — was reimbursed at $136 for physician’s offices, while payment for hospital outpatient departments was 106% higher, at $280…. This year, this payment disparity has jumped to 158%, with physician reimbursement declining to $129 and the outpatient department rate increasing to $333….
The FDA Hinders the Progress of Regenerative Medicine
The U.S. Food and Drug Administration (FDA) sometimes gets lost in a bureaucratic maze of confusion and red tape that deprives patients of beneficial therapies. Innovative products sometimes fall within a gray area and become overly regulated. One of the FDA’s latest targets is regenerative medicine.
An article titled, An MBA in Regulatory Confusion, talks about Florida-based Regenative Labs. The firm manufactures products made from umbilical cords (donated by mothers after a C-section, according to the company website). English physician and anatomist Thomas Wharton first described his namesake umbilical cord jelly in 1656, although he had no way of knowing it is rich in stem cells and regenerative healing properties.